6 Comments
 

i heard from credible sources that 30-40% of pay is cash, then some stock that vests immediately, and some that is restricted for certain periods of time.

 
Best Response

If you didn't start at the bank you currently work in as an MD, you were probably bought out of your unvested stock and non-cash compensation. Plus a large portion of your signing bonus etc was probably paid in stock (over 50% to get you focused). I know at certain banks the vesting period on options like these are in the 5-6 year range.

Usually, unless you are leaving the banking/PE/HF world all together you can get someone to buy up the outstanding obligation in a like-for-like basis. Really it only matters at the end of your career. I know a few MDs who have stuck around making almost no money and being generally unhelpful because they have a year or two left till their options vest from a previous firm, then they are out.

--There are stupid questions, so think first.
 

For the most part, stock options are relatively out of favor on Wall Street. I remember some option and SAR activity in the '99-'01 period, but with the advent of the mandatory expensing of options under GAAP and the relative benefits of using restricted stock, most firms have gravitated towards the issuance of restricted stock rather than options or stock appreciation rights.

The way that it works is generally your base pay is all cash, naturally. Your bonus, which is usually euphemistically labelled "incentive compensation", is all cash to a threshold. Most of the time, that threshold is earnings based. So perhaps the firm will exempt the first, say $150,000 of incentive comp making that part all cash. Then it will rachet up to maybe 20% for the next bucket, with increasing stock portions for each higher bucket of compensation. The maximum might be 50% stock. Or it might be 100% (see UBS for details). 50% would be considered a reasonable top bracket mix. 100% would generally be seen as offensive unless you are making ballplayer money.

I have never seen firms issue unrestricted stock. Why? Because: what's the point of that? The whole point of issuing stock is for retention purposes - it handcuffs you from leaving for a competitor, forcing them to buy you out to make it worth your while to leave. Given you unrestricted stock is like handing you cash. The only advantage might be if your firm has no money to hand you. That's a bad thing.

So what's market for vesting of restricted stock? Generally, three years is reasonable. Some firms push it to four years. Mostly it is equal vesting, although some firms might do 50% after two and 100% after three for example. Some small portion might be cliff vesting (that is, none of it vests until the very end), but that's not very popular - people tend to react viscerally to cliff vest as being a big "fuck you" type instrument. On the rare occasions I've been jammed with three year cliff vest, my personal reaction has been "fine, I'll take it, but I place absolutely zero value on it."

As for issuance price, some firms issue that face value amount at up to a 15% discount to market, but often it is struck at market price on the date of issuance.

There it is. Now you don't have to walk into your MD's office and ask the embarassing question.

 

Voluptas vero accusantium error atque quia. Culpa assumenda temporibus facilis aut molestiae ea. Voluptatum dolore autem eos quis vero.

A et animi rerum saepe officia illum. Voluptas voluptatem nulla id facilis aperiam velit. At at qui asperiores quisquam.

Asperiores reiciendis quo enim modi sint. Rerum magni assumenda sed ipsum sit cupiditate. Necessitatibus voluptas est vero dolorum ipsam voluptatem dolor. Et laudantium rem nostrum totam qui consequatur.

Career Advancement Opportunities

June 2026 Investment Banking

  • Evercore 01 99.4%
  • Moelis & Company 01 98.8%
  • JPMorgan 01 98.2%
  • Guggenheim Partners 01 97.7%
  • Morgan Stanley 07 97.1%

Overall Employee Satisfaction

June 2026 Investment Banking

  • Moelis & Company No 99.4%
  • Morgan Stanley 01 98.8%
  • Evercore 01 98.2%
  • BMO Capital Markets 12 97.6%
  • Banco Santander 01 97.1%

Professional Growth Opportunities

June 2026 Investment Banking

  • Moelis & Company No 99.4%
  • Evercore No 98.8%
  • Morgan Stanley 05 98.2%
  • JPMorgan No 97.7%
  • BMO Capital Markets 12 97.1%

Total Avg Compensation

June 2026 Investment Banking

  • Vice President (14) $434
  • Associates (43) $259
  • 3rd+ Year Analyst (8) $210
  • 2nd Year Analyst (22) $179
  • Intern/Summer Associate (13) $156
  • 1st Year Analyst (75) $151
  • Intern/Summer Analyst (67) $101
notes
16 IB Interviews Notes

“... there’s no excuse to not take advantage of the resources out there available to you. Best value for your $ are the...”

Leaderboard

1
redever's picture
redever
99.2
2
BankonBanking's picture
BankonBanking
99.0
3
kanon's picture
kanon
99.0
4
Secyh62's picture
Secyh62
99.0
5
CompBanker's picture
CompBanker
98.9
6
DrApeman's picture
DrApeman
98.9
7
dosk17's picture
dosk17
98.9
8
Betsy Massar's picture
Betsy Massar
98.9
9
GameTheory's picture
GameTheory
98.9
10
bolo up's picture
bolo up
98.8
success
From 10 rejections to 1 dream investment banking internship

“... I believe it was the single biggest reason why I ended up with an offer...”